| P2093 | author name string | Leonard Hymes | |
| P2860 | cites work | Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy | Q34497495 |
| | BK virus nephritis after renal transplantation | Q36361588 |
| | Higher levels of leflunomide are associated with hemolysis and are not superior to lower levels for BK virus clearance in renal transplant patients | Q36662024 |
| | BK virus infection, replication, and diseases in pediatric kidney transplantation. | Q36766487 |
| | Aggressive immunosuppression minimization reduces graft loss following diagnosis of BK virus-associated nephropathy: a comparison of two reduction strategies | Q36947285 |
| | Use of leflunomide in the treatment of polyomavirus BK-associated nephropathy | Q37310698 |
| | The decade of polyomavirus BK-associated nephropathy: state of affairs | Q37417381 |
| | Polyomavirus (BK) in pediatric renal transplants: evaluation of viremic patients with and without BK associated nephritis | Q43738683 |
| | Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients | Q44104230 |
| | Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults | Q44289414 |
| | Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches | Q44419275 |
| | BK virus-specific antibodies and BKV DNA in renal transplant recipients with BKV nephritis | Q44571746 |
| | Collecting duct carcinoma arising in association with BK nephropathy post-transplantation in a pediatric patient. A case report with immunohistochemical and in situ hybridization study | Q45015114 |
| | Polyomavirus infection in pediatric renal transplant recipients: evaluation using a quantitative real-time PCR technique | Q45058926 |
| | Polyomavirus nephropathy in pediatric kidney transplant recipients | Q45171047 |
| | Intermediate dose cidofovir does not cause additive nephrotoxicity in BK virus allograft nephropathy | Q45394582 |
| | Outcome of management strategies for BK virus replication in pediatric renal transplant recipients | Q45396838 |
| | BK virus nephropathy in pediatric renal transplant recipients: an analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry | Q45401118 |
| | Human polyoma virus-associated interstitial nephritis in the allograft kidney | Q45751593 |
| | The prevalence of BK viremia and urinary viral shedding in a pediatric renal transplant population: a single-center retrospective analysis. | Q54591380 |
| | Detection of polyomavirus BK and JC in children with kidney diseases and renal transplant recipients. | Q54644711 |
| | BK viral infection in an Australian pediatric renal transplant population. | Q54701671 |
| | Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss | Q77312467 |
| | Surveillance renal transplant biopsies and subclinical rejection at three months post-transplant in pediatric recipients | Q80611071 |
| P433 | issue | 1 | |
| P921 | main subject | kidney disease | Q1054718 |
| P304 | page(s) | 28-31 | |
| P577 | publication date | 2009-10-17 | |
| P1433 | published in | Transplantation Reviews | Q15749559 |
| P1476 | title | BK virus nephropathy: a pediatric nephrologist's perspective | |
| P478 | volume | 24 | |